EYDELMAN MIKHAIL (SVP, Gen Counsel & Corp Sec) sold 10.7% of their position (5K shares) of VAXCYTE, INC. on the open market
Open‑market sale worth $353.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/7/2025ACC: 0001649094-25-000045
Officer· SVP, Gen Counsel & Corp Sec
Since Apr 2022
-5K
Net shares
Net seller
$353.7K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+5K
Price / share
$21.41
Trade value
$107.05K
% of position
12.0%
3/5/2025
41.62K→46.62K
Common Stock
Direct
Shares
−2.62K
Price / share
$70.39
Trade value
$184.49K
% of position
5.6%
3/5/2025
46.62K→44K
Common Stock
Direct
Shares
−2.27K
Price / share
$71.07
Trade value
$161.11K
% of position
5.2%
3/5/2025
44K→41.73K
Common Stock
Direct
Shares
−112.00
Price / share
$72.37
Trade value
$8.11K
% of position
0.3%
3/5/2025
41.73K→41.62K
Total
Net shares
+0.00
Net value
-$246.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2025 | M · Option Exercise | +5K | $21.41 | $107.05K | 12.0% | 41.62K | 46.62K |
| Common Stock Direct | 3/5/2025 | S · Sale | −2.62K | $70.39 | $184.49K | 5.6% | 46.62K | 44K |
| Common Stock Direct | 3/5/2025 | S · Sale | −2.27K | $71.07 | $161.11K | 5.2% | 44K | 41.73K |
| Common Stock Direct | 3/5/2025 | S · Sale | −112.00 | $72.37 | $8.11K | 0.3% | 41.73K | 41.62K |
| Total | +0.00 | -$246.65K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
21.41
Held after
144.50K
Exercisable
—
3/5/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock5K shares | 3/5/2025 | M · Option Exercise | −5K | 21.41 | — | 144.50K |